ABL-specific tyrosine kinase inhibitor imatinib as salvage therapy in a child with Philadelphia chromosome-positive acute mixed lineage leukemia (AMLL)
Wissenschaftlicher Artikel
Authors
Selle, B
Bar, C
Hecker, S
Schmidt-Rohr, U
Viehmann, S
Institutions
UKU. Klinik für Kinder- und JugendmedizinPublished in
Leukemia ; 16 (2002), 7. - S. 1393-1395. - ISSN 0887-6924